ArticleInternational journal of biological sciences2024

HDAC Inhibition Sensitize Hepatocellular Carcinoma to Lenvatinib via Suppressing AKT Activation.

Shuai Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.